A detailed history of Arizona State Retirement System transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 22,932 shares of RNA stock, worth $729,696. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,932
Previous 19,965 14.86%
Holding current value
$729,696
Previous $815,000 29.2%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$37.21 - $48.14 $110,402 - $142,831
2,967 Added 14.86%
22,932 $1.05 Million
Q2 2024

Aug 05, 2024

BUY
$22.73 - $40.85 $9,205 - $16,544
405 Added 2.07%
19,965 $815,000
Q1 2024

May 07, 2024

BUY
$9.16 - $25.52 $27,379 - $76,279
2,989 Added 18.04%
19,560 $499,000
Q4 2023

Jan 24, 2024

BUY
$4.87 - $9.37 $2,137 - $4,113
439 Added 2.72%
16,571 $149,000
Q3 2023

Nov 06, 2023

SELL
$6.3 - $11.35 $4,869 - $8,773
-773 Reduced 4.57%
16,132 $102,000
Q2 2023

Aug 01, 2023

BUY
$10.62 - $17.34 $15,919 - $25,992
1,499 Added 9.73%
16,905 $187,000
Q1 2023

Apr 27, 2023

BUY
$15.35 - $25.65 $67,156 - $112,218
4,375 Added 39.66%
15,406 $236,000
Q4 2022

Feb 07, 2023

BUY
$10.06 - $22.66 $8,943 - $20,144
889 Added 8.77%
11,031 $244,000
Q3 2022

Nov 07, 2022

BUY
$15.46 - $23.43 $156,795 - $237,627
10,142 New
10,142 $166,000
Q1 2022

May 04, 2022

SELL
$14.2 - $23.78 $130,498 - $218,538
-9,190 Closed
0 $0
Q4 2021

Feb 04, 2022

SELL
$20.4 - $28.66 $2,631 - $3,697
-129 Reduced 1.38%
9,190 $218,000
Q3 2021

Nov 12, 2021

BUY
$18.16 - $25.21 $169,233 - $234,931
9,319 New
9,319 $230,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.66B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.